logo

For the Inventor, By the Inventor

Brookline, NH, United States of America

Dennis Kujawski

This inventor holds 10 USPTO granted patents. Top assignee: C. R. Bard, Inc.. Active years: 1989-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis Kujawski. Retrieved from https://idiyas.com/inventor/dennis-kujawski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 90.0

Average Co-Inventor Count = 1.7

ph-index = 10

Forward Citations = 2,449(Granted Patents)


Location History:

  • Nashua, NH (US) (1989)
  • Brookline, NH (US) (1993 - 2005)

Company Filing History:

goldMedal10 out of 1,761 
 
C. R. Bard, Inc.
 patents

Years Active: 1989-2005

Loading Chart...
10 patents (USPTO):Explore Patents
1. 6878164 - Short body endoprosthesis (2005-04-12),
2. 6306164 - Short body endoprosthesis (2001-10-23),
3. 6077297 - Non-migrating vascular prosthesis and minimally invasive placement (2000-06-20),
4. 5935161 - Non-migrating vascular prosthesis and minimally invasive placement (1999-08-10),
5. 5891193 - Non-migrating vascular prosthesis and minimally invasive placement (1999-04-06),
6. 5860998 - Deployment device for tubular expandable prosthesis (1999-01-19),
7. 5733325 - Non-migrating vascular prosthesis and minimally invasive placement system (1998-03-31),
8. 5284138 - Apparatus and method for positioning a sensor away from the blood vessel (1994-02-08),
9. 5265606 - System and technique for measuring blood characteristics by centering a (1993-11-30),
10. 4795434 - Apparatus for positioning a sensor in vivo (1989-01-03),

Title: Dennis Kujawski: A Pioneer in Vascular Innovation

Introduction

Dennis Kujawski, an accomplished inventor based in Brookline, NH, has made significant contributions to the field of medical devices. With a portfolio of 10 patents to his name, Kujawski's innovative designs are making waves in the treatment of vascular defects, particularly in addressing abdominal aortic aneurysms. His expertise and dedication have positioned him as a prominent figure in the medical device industry.

Latest Patents

One of Kujawski's latest inventions is the short body endoprosthesis, which is designed to treat vascular defects, including abdominal aortic aneurysms. This endoprosthetic implant features a short main body that can be strategically placed within a patient's aorta, just above the renal end of an aortic aneurysm. The proximal, or renal, face of the implant redirects blood flow into openings that channel blood past the aneurysm. This innovative design allows blood traveling through the aorta to be carried by a vascular graft that spans the aneurysm, relieving fluid pressure on the thin wall and significantly reducing the risk of fatal ruptures.

Career Highlights

Dennis Kujawski is currently associated with C. R. Bard, Inc., a well-regarded company in the medical device sector. His passion for innovation is evident in his commitment to developing life-saving solutions for patients suffering from vascular issues. Over the years, his work has contributed to advancing medical technology and improving patient outcomes.

Collaborations

Throughout his career, Kujawski has worked closely with talented professionals, including colleagues Michael F. Weiser and Timothy Robinson. Their collaborative efforts have further enhanced the creativity and effectiveness of the projects they tackle, fostering an environment of innovation and shared knowledge.

Conclusion

Dennis Kujawski stands as a testament to the power of innovation in medicine. His dedication to creating groundbreaking solutions for vascular treatments exemplifies the impact an inventor can have on healthcare. As he continues to develop new technologies, his contributions will undoubtedly continue to influence the industry and improve patients' lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…